spectrumCEUTICALS - SB 500

Suppie Report

spectrumCEUTICALS

SB 500

A grade
90/100
SUPPIE SCORE
78/100
EFFICACY
High
SAFETY
98/100
CLEANLINESS

What Does SB 500 Do?

SB 500 delivers a clinically relevant 10 billion CFU of well-researched Saccharomyces boulardii strain DBVPG 6763 per capsule, shown in multiple studies to reduce traveller's diarrhoea risk and support gut flora.
How does Saccharomyces boulardii help with traveller's diarrhoea?
What is the recommended dosage and timing for SB 500?
Is SB 500 suitable to take alongside antibiotics?
Chat with Suppie

What Are the Benefits of SB 500?

Based on proven scientific research

Traveller's DiarrhoeaStrong
Intestinal HealthModerate
Gut Flora BalanceModerate
Gastrointestinal SupportModerate

Good For:

What Are the Side Effects of spectrumCEUTICALS SB 500?

Always consult your health practitioner if in doubt.

RiskLow Risk

Overview

500 mg (10 billion CFU) Saccharomyces boulardii per capsule is a standard therapeutic dose with established safety in adults for short-term use.
Generally well-tolerated; mild digestive upset such as gas or bloating may occur initially in sensitive individuals.
Seek medical advice if diarrhoea persists beyond 48 hours in adults or shorter times in children per label warnings.
Suitable for vegans; gluten, dairy, and artificial additive free with no major allergens declared.
Room temperature stable; no refrigeration required.

Potential Side Effects

Negative Interactions

Inactive Ingredients

Hypromellose
Low Risk

What Are the Ingredients in spectrumCEUTICALS SB 500?

Saccharomyces cerevisiae (boulardii) strain DBVPG 6763
500 mg equiv. 10 billion CFU
hypromellose

Scan the bottle in your cupboard

Same graded report you just read — on any label, in about 10 seconds.

Download on the App Store

Dosage & Bioavailability

How the active doses and forms in SB 500 compare to the research.

Saccharomyces cerevisiae (boulardii) strain DBVPG 6763 is listed at 500 mg equiv. 10 billion CFU per serving; without a source-specific reference range, dose adequacy cannot be graded.
Saccharomyces cerevisiae (boulardii) strain DBVPG 6763 has no distinct chemical or delivery form stated, so no product-specific absorption advantage can be established.

Frequently Asked Questions

Common questions about spectrumCEUTICALS SB 500